Recipharm Pathway to Clinic®

Recipharm’s Pathway to Clinic® offering takes new molecules seamlessly and speedily from formulation development to first in human (FIH) studies. Through a close partnership between Clinical Trial Consultants (CTC) and Recipharm, experts in conducting hospital-based clinical trials with patients, we take responsibility for the full phase I programme, reducing the complexity of your FIH projects.

Learn more about our capabilities by downloading our fact sheet below.
 
/sites/default/files/media/FactSheet_Recipharm-Pathway-to-Clinic%C2%AE.pdf
False
False